Literature DB >> 24371137

GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability.

Ebba Gregorsson Lundius1, Vladana Vukojevic, Ellen Hertz, Nikolas Stroth, Andreas Cederlund, Masao Hiraiwa, Lars Terenius, Per Svenningsson.   

Abstract

The subcellular distribution of the G protein-coupled receptor GPR37 affects cell viability and is implicated in the pathogenesis of parkinsonism. Intracellular accumulation and aggregation of GPR37 cause cell death, whereas GPR37 located in the plasma membrane provides cell protection. We define here a pathway through which the recently identified natural ligand, prosaposin, promotes plasma membrane association of GPR37. Immunoabsorption of extracellular prosaposin reduced GPR37(tGFP) surface density and decreased cell viability in catecholaminergic N2a cells. We found that GPR37(tGFP) partitioned in GM1 ganglioside-containing lipid rafts in the plasma membrane of live cells. This partitioning required extracellular prosaposin and was disrupted by lipid raft perturbation using methyl-β-cyclodextrin or cholesterol oxidase. Moreover, complex formation between GPR37(tGFP) and the GM1 marker cholera toxin was observed in the plasma membrane. These data show functional association between GPR37, prosaposin, and GM1 in the plasma membrane. These results thus tie together the three previously defined components of the cellular response to insult. Our findings identify a mechanism through which the receptor's natural ligand and GM1 may protect against toxic intracellular GPR37 aggregates observed in parkinsonism.

Entities:  

Keywords:  Fluorescence Correlation Spectroscopy; G Protein-coupled Receptors (GPCR); Ganglioside; Lipid Raft; Pael-R; Parkinson Disease

Mesh:

Substances:

Year:  2013        PMID: 24371137      PMCID: PMC3931029          DOI: 10.1074/jbc.M113.510883

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Conformational and amino acid residue requirements for the saposin C neuritogenic effect.

Authors:  X Qi; K Kondoh; D Krusling; G J Kelso; T Leonova; G A Grabowski
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

2.  Fluorescence cross-correlation: a new concept for polymerase chain reaction.

Authors:  R Rigler; Z Földes-Papp; F J Meyer-Almes; C Sammet; M Völcker; A Schnetz
Journal:  J Biotechnol       Date:  1998-08-12       Impact factor: 3.307

3.  Visualizing association of lipidated signaling proteins in heterogeneous membranes--partitioning into subdomains, lipid sorting, interfacial adsorption, and protein association.

Authors:  Katrin Weise; Gemma Triola; Sascha Janosch; Herbert Waldmann; Roland Winter
Journal:  Biochim Biophys Acta       Date:  2009-12-16

4.  Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor.

Authors:  B F Roettger; D Ghanekar; R Rao; C Toledo; J Yingling; D Pinon; L J Miller
Journal:  Mol Pharmacol       Date:  1997-03       Impact factor: 4.436

5.  Prosaposin receptor: evidence for a G-protein-associated receptor.

Authors:  M Hiraiwa; W M Campana; B M Martin; J S O'Brien
Journal:  Biochem Biophys Res Commun       Date:  1997-11-17       Impact factor: 3.575

6.  Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells.

Authors:  W M Campana; M Hiraiwa; J S O'Brien
Journal:  FASEB J       Date:  1998-03       Impact factor: 5.191

7.  Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis.

Authors:  D Marazziti; A Gallo; E Golini; R Matteoni; G P Tocchini-Valentini
Journal:  Genomics       Date:  1998-11-01       Impact factor: 5.736

8.  Colocalization and complex formation between prosaposin and monosialoganglioside GM3 in neural cells.

Authors:  R Misasi; M Sorice; T Garofalo; T Griggi; W M Campana; M Giammatteo; A Pavan; M Hiraiwa; G M Pontieri; J S O'Brien
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

9.  Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor.

Authors:  R Pfeiffer; J Kirsch; F Fahrenholz
Journal:  Exp Cell Res       Date:  1998-10-10       Impact factor: 3.905

10.  Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line.

Authors:  A Navarro; R Zapata; E I Canela; J Mallol; C Lluis; R Franco
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

View more
  15 in total

1.  GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant.

Authors:  Michelle M Giddens; Jennifer C Wong; Jason P Schroeder; Emily G Farrow; Brilee M Smith; Sharon Owino; Sarah E Soden; Rebecca C Meyer; Carol Saunders; J B LePichon; David Weinshenker; Andrew Escayg; Randy A Hall
Journal:  Neurobiol Dis       Date:  2017-07-06       Impact factor: 5.996

2.  Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.

Authors:  Brilee M Smith; Michelle M Giddens; Jessica Neil; Sharon Owino; TrangKimberly T Nguyen; Duc Duong; Fengqiao Li; Randy A Hall
Journal:  Neuroscience       Date:  2017-06-20       Impact factor: 3.590

Review 3.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

4.  Dopamine Receptor Signaling in MIN6 β-Cells Revealed by Fluorescence Fluctuation Spectroscopy.

Authors:  Brittany Caldwell; Alessandro Ustione; David W Piston
Journal:  Biophys J       Date:  2016-08-09       Impact factor: 4.033

Review 5.  Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism.

Authors:  Nahid Tayebi; Grisel Lopez; Jenny Do; Ellen Sidransky
Journal:  Trends Mol Med       Date:  2020-09-15       Impact factor: 11.951

6.  Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.

Authors:  Myles R McCrary; Michael Q Jiang; Michelle M Giddens; James Y Zhang; Sharon Owino; Zheng Z Wei; Weiwei Zhong; Xiaohuan Gu; Huang Xin; Randy A Hall; Ling Wei; Shan P Yu
Journal:  FASEB J       Date:  2019-07-03       Impact factor: 5.834

7.  GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells.

Authors:  E Hertz; L Terenius; V Vukojević; P Svenningsson
Journal:  Neuropharmacology       Date:  2018-11-10       Impact factor: 5.250

8.  Quantitative Proteomics Reveal an Altered Pattern of Protein Expression in Brain Tissue from Mice Lacking GPR37 and GPR37L1.

Authors:  TrangKimberly Thu Nguyen; Eric B Dammer; Sharon A Owino; Michelle M Giddens; Nora S Madaras; Duc M Duong; Nicholas T Seyfried; Randy A Hall
Journal:  J Proteome Res       Date:  2020-02-07       Impact factor: 4.466

Review 9.  Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1.

Authors:  Nicola J Smith
Journal:  Front Pharmacol       Date:  2015-11-17       Impact factor: 5.810

10.  Spatiotemporal Control of GPR37 Signaling and Its Behavioral Effects by Optogenetics.

Authors:  Wu Zheng; Jianhong Zhou; Yanan Luan; Jianglan Yang; Yuanyuan Ge; Muran Wang; Beibei Wu; Zhongnan Wu; Xingjun Chen; Fei Li; Zhihui Li; Sergii Vakal; Wei Guo; Jiang-Fan Chen
Journal:  Front Mol Neurosci       Date:  2018-03-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.